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Abstract
Background: Fever of unknown origin (FUO) can be defined as a body temperature higher than 38.3°C on several
occasions over more than 3 weeks, the diagnosis of which remains uncertain after 1 week of evaluation. Acute
disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the central nervous system
with a wide range of clinical manifestations. The highest incidence of ADEM is observed during childhood and it
usually occurs following a viral or bacterial infection or, more rarely, following a vaccination, or without a
preceding cause.
Case presentation: Here, we describe an atypical case of ADEM that initially manifested as several weeks of FUO
in a fifteen years old boy.
Conclusions: This case report suggests a new possible syndromic association between ADEM and FUO, which
should be considered in the clinical examination of patients with FUO, especially in the presence of also modest
neurologic or neuropsychiatric symptoms.
Background
Fever of unknown origin (FUO) can be defined as a
body temperature higher than 38.3°C on several occa-
sions over more than 3 weeks, the diagnosis of which
remains uncertain after 1 week of evaluation [1]. Evalua-
tion of FUO in children is complex, because of a wide
range of possible etiologies. The most common causes
of FUO in childhood are viral infections, while in older
patients frequent causes are inflammatory illnesses
(rheumatic diseases, vasculitides, polymyalgia rheumatic,
sarcoidosis), infections and neoplasms [1,2]. Acute disse-
minated encephalomyelitis (ADEM) is uncommon
inflammatory demyelinating disease of the central ner-
vous system (CNS) with a wide range of clinical mani-
festations. The highest incidence of ADEM is observed
during childhood and it usually occurs following a viral
or bacterial infection or, more rarely, following a vacci-
nation, or without a preceding cause [3]. Onset of the
disorder is sudden. According to the classic definition,
ADEM is a monophasic disease, but it can also present
a relapsing course, being described as “recurrent” if the
affected districts are always the same or “multiphasic” if
there is dissemination in space and time of the lesions
[4]. Irritability and lethargy are common first signs of
ADEM. Fever and headache are reported about in half
of patients. Fever in ADEM is frequently associated with
the development of neurologic symptoms, which can
occur after hours or weeks from the onset of illness.
The most common neurologic symptoms are visual field
deficits; language disturbances; mental status abnormal-
ities ranging from irritability and lethargy to coma; psy-
chiatric changes which include depression, personality
changes and psychosis. Meningeal signs are reported in
children with severe disease. Weakness, which may be
hemiparetic or generalized and symmetric, is more com-
monly detected than sensory defects. Other reported
symptoms are cranial nerve palsies, generalized or focal
seizures and ataxia [5-8]. Here we describe an atypical
case of ADEM presenting as FUO.
Case presentation
The patient was an Italian boy of fifteen years old who
was admitted to the pediatric department of the Univer-
sity of Naples “Federico II” for persistent fever from 25
days with inconstant headache, asthenia and a state of
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examination didn’t reveal any sign of localization of
fever. Familial history was unremarkable except for his
sister who had used drugs in the past and was suffering
from hepatitis C virus (HCV) infection. Personal history
revealed only allergic rhinitis with positive skin prick
test. The past medical history revealed that he had a
motorcycle accident seven months before. On that occa-
sion a CT of skull was negative. Six months before hos-
pital admission he presented flu like syndrome. A few
months before he showed a state of anxiety character-
ized by tachycardia and agitation. For these symptoms a
neurologist recommended a drug therapy (levosulpiride,
ademetionine and hypothalamic phospholipid lipo-
somes). One week prior to admission at our hospital, he
was admitted at the pediatric unit of Formia hospital for
high-spiking fever, which was poor responsive to parace-
tamol, and inconstant headache. During the previous
admission, a definitive documentation of fever and
exclusion of factitious fever were obtained. A total body
CT scanning was performed in order to exclude conse-
quences of the previous motorcycle accident. The fol-
lowing laboratory studies, which were carried out on
several occasions, resulted within the normal range:
complete blood count (CBC); peripheral blood smear;
inflammatory indexes (erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP), serum protein electro-
phoresis (SPEP), assay of immunoglobulins) (Table 1);
serum chemistry; urine and blood culture; throat and
urethral swab; serology for viral hepatitis, human immu-
nodeficiency virus (HIV), cytomegalovirus (CMV),
Epstein-Barr virus (EBV), herpes simplex viruses (HSV),
rubella and bartonella infection, brucellosis, chlamydial
diseases, typhoid and paratyphoid A and B fever, rickett-
siosis, syphilis and toxoplasmosis; Mantoux test and
rapid test for Malaria; immunologic screening (antinuc-
lear antibodies, antimitochondrial antibodies, rheumato-
logic factor and C3-C4); thyroid hormones, cortisol,
ACTH, aldosterone, angiotensin-converting enzyme;
blood lead and toxicological investigations for benzodia-
zepines, opiates, methadone, cocaine, cannabis, amphe-
tamines. The patient also underwent the following
exams: chest and skull radiography, abdominal ultraso-
nography, total body CT scanning and color flow Dop-
pler echocardiography, but these imaging studies failed
to disclose the diagnosis. Appropriate consultations
were indicated based on patient history, including the
following: infectious disease specialist, hematologist and
neurologist. Hematologist asked for a bone marrow aspi-
rate, which resulted negative for the research of leuke-
mia and other myeloproliferative disorders. This detailed
workup was helpful to exclude the most common causes
of FUO: factitious fever, infectious diseases, neoplasms,
immunodeficiencies, autoimmune diseases, vasculitides,
endocrine disorders, drug fever and inflammatory bowel
diseases. Despite negative exams, he still had fever and
was in a poor state of health. The clinical examination
did not show any sign of localization of fever. His head-
ache and panic state got worse, so an immediate
ophthalmologic visit was performed. The exam of fun-
dus oculi showed: fade borders of optical disc, raised on
retinal surface (left eye > right eye). Normal macula.
Increased vascular tortuosity. A cranial magnetic reso-
nance (MRI) was urgently ordered. The MRI showed
some areas of hyperintensity in T2-weighted and Fluid-
attenuated Inversion Recovery (FLAIR) images. These
areas were in several regions of brain. They were typical
of an inflammatory autoimmune disease, like ADEM
(Figure 1). The next day the patient underwent an EEG,
which showed suffering of temporal right areas of brain.
A lumbar puncture with cerebrospinal fluid (CSF) analy-
sis revealed elevated protein content (92 mg/dl), normal
glucose content (5.2 mmol/L, compared to a random
blood glucose level 7.5 mmol/L) and leucocytosis, pre-
dominantly lymphocytosis (100 lymphocytes cell/mm
3).
The opening pressure was normal (17 cm CSF). CSF oli-
goclonal bands of IgG were negative. Their presence was
more often associated with Multiple Sclerosis (MS), the
Table 1 Laboratory data: complete and differential blood
count, inflammatory indexes (erythrocyte sedimentation
rate (ESR), C-reactive protein (CRP), serum protein
electrophoresis (SPEP), assay of immunoglobulins)
White blood cells (× 10
3/μL) 8.81
Red blood cells (× 10
6/μL) 5.02
Platelets (× 10
3/μL) 256
Hemoglobin (g/dl) 12.9
Hematocrit (%) 38.3
Neutrophils (%) 71.9
Lymphocytes (%) 19.7
Monocytes (%) 7.5
Eosinophils (%) 0.6
Basophils (%) 0.3
ESR (mm/h) 10
CRP (mg/L) 0.03
Total protein (g/dl) 6.6
IgG (mg/dl) 1112
IgA (mg/dl) 309
IgM (mg/dl) 74
Albumin (g/dL) 64.4
Alpha 1 (g/dL) 2.7
Alpha 2 (g/dL) 10.1
Beta (g/dL) 9.0
Gamma (g/dL) 13.8
A/G 1.81
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culture and an extensive microbiologic workup for
bacterial and viral infection of CNS have been helpful
in distinguishing ADEM from various infectious forms
of meningoencephalitis. Acute infectious encephalitis
m a yb ec a u s e db yaw i d er a n g eo fv i r u s e sb u tt h em o s t
important is herpes simplex encephalitis (HSE) because
of its severity, especially if untreated, and its good
response to specific treatment with acyclovir. Analysis
of the CSF for HSV DNA using the Polymerase Chain
Reaction (PCR) has been a significant advance in the
diagnosis of HSE as this test has a very high sensitivity
and specificity especially with appropriate sample tim-
ing [9]. In our patient serology for HSV and analysis of
CSF for HSV DNA resulted negative, thus the diagno-
sis of HSE was ruled out. CNS vasculitides may also
result in syndromes resembling ADEM, but negative
serum markers of inflammation, immunologic screen-
ing and CSF analysis didn’t favor this diagnostic
hypothesis. Moreover neuroimaging showed demyeliza-
tion areas, typical of an autoimmunitary inflammatory
disease like ADEM, so we immediately started therapy
with high doses of glucocorticoids e.v. The patient
received 1 g/die of methylprednisolone for 5 days, and
then he continued the therapy with progressive
decreased doses of methylprednisolone by oral way
[4,8]. Patient conditions quickly improved. Fever disap-
peared and headache decreased. He still had panic and
anxiety, so he started a therapy with dipotassium clora-
zepate (5 mg/die), with improvement of symptoms.
After 6 days of therapy, the patient repeated ophthal-
mologic visit; fundus oculi still showed mild signs of
intracranial hypertension. After 13 days of therapy
patient repeated cranial MRI, which showed complete
resolution of the lesions. The patient was discharged in
a good state of health, with a domiciliary therapy. He
stopped glucocorticoids therapy after 1 month. He also
underwent a last ophthalmologic visit and the fundus
oculi was normal. After three and six months, at follow
up examination no neurologic symptoms were found.
At the follow up we re-evaluated the diagnosis of
ADEM, because many patients initially diagnosed with
ADEM develop clinically definite MS. The final diag-
nosis of ADEM was only established because there was
no evidence of a second clinical and neuroradiologic
episode of CNS demyelination.
Conclusions
Acute disseminated encephalomyelitis (ADEM) is an
immune-mediated inflammatory disorder of the CNS
characterized by a widespread demyelization that predo-
minantly involves the white matter of the brain and
spinal cord. The condition is usually precipitated by a
viral infection or vaccination [10] and is more frequent
in children. Today the exact incidence of ADEM is little
known. In one study of children with ADEM living in
San Diego County, California, the incidence was esti-
mated to be at least 0.4/100.000/year [11], but in the
last decade ADEM has been increasingly diagnosed as
more magnetic resonance imaging studies are performed
on patients with acute encephalopathy. Based on its
immune-mediated etiology, ADEM is commonly treated
with high-dose steroids. Factors influencing treatment
efficacy and possible alternative options for steroid resis-
tant cases remain unclear. In a portion of patients who
fail to respond to steroid therapy, intravenous immuno-
globulin has been used with some benefit. Unsolved
issues regard clinical predictors to best select therapy
for groups of patients. Plasmapheresis and cytostatic
drugs are alternative treatment options in patients who
do not respond to steroid and/or to intravenous immu-
noglobulins [8]. An acute encephalopathy with multifo-
cal neurologic signs and deficits is usually the first
clinical manifestation, but ADEM has a wide range of
presenting features. We described an atypical case of
ADEM that initially manifested as several weeks of
FUO. A successful diagnosis of the underlying disease
required an intensive and rational diagnostic evaluation
of the wide spectrum of possible etiologies of FUO. This
case report suggests a new possible syndromic associa-
tion between ADEM and FUO, which should be consid-
ered in the clinical examination of patients with FUO,
especially in the presence of also modest neurologic or
neuropsychiatric symptoms.
Figure 1 Transverse T2-weighted MRI brain image shows small
high-signal lesions on the lateral right side of the pontine
tegmentum.
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